Enregistrement :
37
de
41
(2023-07-12
à
2024-05-15)
Politique ou Programme
Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries
Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages and discussion on COVID19 potential impacts
Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's life sciences & biomanufacturing strategy
The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability.
Politique ou Programme, Proposition législative, Projet de loi ou résolution, Règlement
Consider amendments to the Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of potential importation legislation in the United States.
Discussions around the World Trade Organization consideration of a TRIPS Patent Waiver
Monitoring and engaging on the Government’s commitment to create a national strategy for rare diseases; the Canadian Drug Agency; and the development of a pharmacare legislation.
Politique ou Programme, Règlement
Engage the Federal Government on Health Canada’s Regulatory Innovation Agenda (Agile Licensing Modernization) to discuss opportunities for further harmonization; flexibility and predictability in the new regulatory framework being develop and its linkage to pillar 5 of the Biomanufacturing and Life Sciences Strategy.
Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related proposed guidelines.
Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Agency for Drugs and Technologies in Health (CADTH)/Common Drug Review as well as the review times and processes conducted by Health Canada for the purpuse of obtaining a notice of compliance.
Politique ou Programme, Subvention, Contribution ou autre avantage financier
Advocacy to maintain and increase funding for the National Immunization Strategy and discussions on vaccine procurement.
Proposition législative, Projet de loi ou résolution
Monitoring and engaging the Government and Parliamentarians on the House of Commons Standing Committee on Public Accounts (PACP) motion related to the discloser on vaccine contracts
Subvention, Contribution ou autre avantage financier
Discussions on the procurement of a COVID19 vaccine and therapy